drugset / Trial / NCT02889133

Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality

NCT02889133

RandomizedParallel-groupTriple-blindBasic science

Summary

Primary Hypothesis * The 24-hour post-transfusion RBC recovery of units obtained from donors exhibiting iron-deficient erythropoiesis will not meet FDA standards for clinical use. * The 24-hour post-transfusion RBC recovery of units obtained after intravenous iron repletion will improve significantly and will meet FDA standards for clinical use.

Timeline

Start
2017-01
Primary completion
2021-10-05
Completion
2021-10-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iron dextran Unknown 1 g Intravenous